Cannabinoid CB1 -receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation-Reference-Cited by-同舟云学术

Cannabinoid CB1 -receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

Published:2001-10 Issue:3 Volume:134 Page:563-570
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Izzo Angelo A,Fezza Filomena,Capasso Raffaele,Bisogno Tiziana,Pinto Luisa,Iuvone Teresa,Esposito Giuseppe,Mascolo Nicola,Di Marzo Vincenzo,Capasso Francesco

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0704293/fullpdf

Reference50 articles.

1. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat;BEAULIEU;Eur. J. Pharmacol.,2000

2. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function;BISOGNO;Biochem. Biophys. Res. Commun.,1999

3. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes;BISOGNO;J. Biol. Chem.,1997

4. Control of pain initiation by endogenous cannabinoids;CALIGNANO;Nature,1998

5. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid;CALIGNANO;Eur. J. Pharmacol.,1997

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?;Anandamide in Health and Disease;2025

2. The role of anandamide in digestive and defensive functions of the gut;Anandamide in Health and Disease;2025

3. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model;Journal of Pharmacology and Experimental Therapeutics;2024-07-15

4. Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases;International Journal of Molecular Sciences;2024-06-18

5. Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837;British Journal of Pharmacology;2024-06-17